[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351794-105":59,"doc-detail-351794-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mapping-metabolic-reprogramming-in-lung-and-breast-cancer-through-integrative-bioinformatics-read-online-free","Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics - read online free","","Metabolic reprogramming drives cancer proliferation, stress resistance, and therapeutic adaptation, yet metabolic alterations vary widely across tumor types. The study builds a unified integrative bioinformatics framework combining UALCAN transcriptomics, DGIdb drug–gene links, Open Targets gene–disease associations, Enrichr pathway enrichment, and STRING/Cytoscape interaction networks. Applied to LUAD, LSCC, BRCA, and MET500, it identifies subtype-specific metabolic programs, prioritized translational metabolic targets, conserved survival pathways, and a G6PD–PGD hub linking glucose uptake, redox balance, and nucleotide biosynthesis, further contextualized with survival and clinical trial screening.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mapping-metabolic-reprogramming-in-lung-and-breast-cancer-through-integrative-bioinformatics-read-online-free/351794/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mapping-metabolic-reprogramming-in-lung-and-breast-cancer-through-integrative-bioinformatics-read-online-free/351794.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What bioinformatics resources and tools were integrated to study metabolic reprogramming?","Question",{"text":112,"@type":113},"The framework integrates UALCAN for transcriptomic profiling, DGIdb for drug–gene interactions, Open Targets for gene–disease associations, Enrichr for pathway enrichment, and STRING/Cytoscape for protein–protein interaction networks.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did metabolic signatures differ across lung and breast cancer subtypes?",{"text":117,"@type":113},"LUAD showed glycolytic activation, LSCC linked glycolysis with oxidative phosphorylation, BRCA favored anabolic and lipogenic pathways, and MET500 tumors adopted stress-adaptive states with elevated antioxidant and autophagy programs.",{"name":119,"@type":110,"acceptedAnswer":120},"Which metabolic targets and pathways were highlighted as key findings?",{"text":121,"@type":113},"Pharmacological evidence prioritized interactions such as ASNS–asparaginase, DHODH–teriflunomide, and G6PD–rasburicase; gene–disease associations emphasized G6PD, SLC2A1, and TK1. Pathway enrichment pinpointed the pentose phosphate pathway, pyrimidine metabolism, and glutathione metabolism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351794,1791176561,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","OPEN ACCESS  \nCitation: Al-Damook N, Sakkal M, Khair M, Mousa WK, Ghemrawi R (2026) Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics. PLoSOne 21(6): e0350628. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0350628](journal.pone.0350628)  \nEditor: Mohammad Zeeshan Najm, Apeejay  \nStya University, INDIA Received: August 29, 2025  \nAccepted: May 15, 2026  \nPublished: June 4, 2026  \nCopyright: © 2026 Al-Damook et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: This study was supported by internal funding from Al Ain University, United Arab Emirates (Grant No. Ph2025-6-102), awarded to R.G. There was no additional external  \nRESEARCH ARTICLE  \nMapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics  \nNosaybaAl-Damook1,2☯, Molham Sakkal1,2☯, Mostafa Khair3, Walaa K. Mousa1,2,4, Rose Ghemrawi1,2*  \n1 College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates, 2 AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates, 3 Core Technology Platforms, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates, 4 College of Pharmacy, Mansoura University, Mansoura, Egypt  \n☯ These authors contributed equally to this work.  \n* [rose.ghemrawi@aau.ac.ae](rose.ghemrawi@aau.ac.ae)  \nAbstract  \nMetabolic reprogramming is central to cancer biology, enabling tumor cells to sustain rapid proliferation, resist stress, and adapt to therapy. However, these alterations are highly heterogeneous across cancer types, and current treatments rarely exploit subtype-specific metabolic vulnerabilities. To address this gap, we developed a unified bioinformatics framework that integrates transcriptomic profiling (UALCAN), drug–gene interactions (DGIdb), gene–disease associations (Open Targets), pathway enrichment (Enrichr), and protein–protein interaction networks (STRING/Cytoscape) . This pipeline was applied to lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LSCC), breast cancer (BRCA), and metastatic breast tumors (MET500) to uncover cancer type–specific metabolic programs and prioritize translational targets. Our analysis revealed distinct signatures: LUAD showed glycolytic activation, LSCC coupled glycolysis with oxidative phosphorylation, BRCA favored anabolic and lipogenic pathways, and MET500 tumors adopted stress-adaptive states with elevated antioxidant and autophagy programs. Integration of pharmacological evidence highlighted clinically actionable interactions between metabolic genes and FDAapproved drugs, including ASNS–asparaginase, DHODH–teriflunomide, and G6PD– rasburicase. Gene–disease associations further prioritized G6PD, SLC2A1, and TK1 as robust targets strongly linked to lung and breast cancers. Pathway enrichment pinpointed the pentose phosphate pathway, pyrimidine metabolism, and glutathione metabolism as conserved axes sustaining tumor survival, while network analysis positioned the G6PD–PGD hub as a central metabolic node connecting glucose uptake, redox balance, and nucleotide biosynthesis. To place these  \nbioinformatics-derived findings within a functional and clinical context, we complemented the computational analyses with patient survival assessment, clinical trial screening, and targeted literature appraisal. Survival analysis demonstrated cancer type–specific prognostic relevance for selected metabolic genes, while clinical and  \nPLOS One | [https://doi.org/10.1371/journal.pone.0350628](https://doi.org/10.1371/journal.pone.0350628) June 4, 2026 1 / 19  \nfunding received for this study. The funder had no role in study design, data","cbCaiaeVxDx4JyKK","https://ap.wps.com/l/cbCaiaeVxDx4JyKK","pdf",1111932,"English","# Abstract\n## Methods overview\n## Tumor-specific metabolic signatures\n## Translational target prioritization\n## Conserved pathway analysis\n## Network-based hub interpretation\n## Functional and clinical context","[{\"question\":\"What bioinformatics resources and tools were integrated to study metabolic reprogramming?\",\"answer\":\"The framework integrates UALCAN for transcriptomic profiling, DGIdb for drug–gene interactions, Open Targets for gene–disease associations, Enrichr for pathway enrichment, and STRING/Cytoscape for protein–protein interaction networks.\"},{\"question\":\"How did metabolic signatures differ across lung and breast cancer subtypes?\",\"answer\":\"LUAD showed glycolytic activation, LSCC linked glycolysis with oxidative phosphorylation, BRCA favored anabolic and lipogenic pathways, and MET500 tumors adopted stress-adaptive states with elevated antioxidant and autophagy programs.\"},{\"question\":\"Which metabolic targets and pathways were highlighted as key findings?\",\"answer\":\"Pharmacological evidence prioritized interactions such as ASNS–asparaginase, DHODH–teriflunomide, and G6PD–rasburicase; gene–disease associations emphasized G6PD, SLC2A1, and TK1. Pathway enrichment pinpointed the pentose phosphate pathway, pyrimidine metabolism, and glutathione metabolism.\"}]","Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics - read online free | PDF",1790095920,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb2d1166ded9436c3e4474f758547748.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b011db8ccb267e82e79c302d786d9ed.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2557d51f3829902079fb7d61c134e9c9.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f622bf6dbb722980e4bbf3004a36a58.webp",980,1268]